Related Experiment Video

Updated: Mar 15, 2026

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

5.7K

Renin-Angiotensin System Control for Chronic Kidney Disease Patients Undergoing Coronary Surgery

Isamu Yoshitake1, Akira Sezai, Mitsumasa Hata

  • 1Department of Cardiovascular Surgery, Nihon University School of Medicine, Tokyo, Japan.

Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia
|August 26, 2016
PubMed

Insights

Active renin-angiotensin-aldosterone system (RAAS) control using human atrial natriuretic peptide (hANP) and an angiotensin II receptor blocker (ARB) improved kidney function and reduced dialysis rates in chronic kidney disease (CKD) patients after coronary artery bypass grafting (CABG).

Area of Science:

  • Nephrology
  • Cardiology
  • Pharmacology

Background:

  • Chronic kidney disease (CKD) poses significant risks for patients undergoing coronary artery bypass grafting (CABG).
  • The renin-angiotensin-aldosterone system (RAAS) plays a crucial role in cardiovascular and renal homeostasis.
  • Effective management of RAAS is vital for improving outcomes in CKD patients undergoing major cardiac surgery.

Purpose of the Study:

  • To investigate the efficacy of active RAAS modulation using human atrial natriuretic peptide (hANP) combined with an angiotensin II receptor blocker (ARB) in CKD patients undergoing CABG.
  • To assess the impact of this combined therapy on renal function and cardiovascular markers post-CABG.

Main Methods:

  • A prospective study involving 286 CKD patients undergoing CABG.
  • Patients were randomized into three groups: placebo, hANP treatment, and active RAAS control therapy (hANP + ARB).
  • Renal function, brain natriuretic peptide (BNP), and RAAS parameters were monitored and analyzed over one year.

Main Results:

  • Active RAAS control (hANP and hANP + ARB) significantly improved renal function compared to placebo.
  • The dialysis rate was markedly reduced in the hANP and active RAAS control groups (1.7-1.8%) versus placebo (12%).
  • BNP and aldosterone levels were significantly lower in the treatment groups, indicating successful RAAS modulation and reduced cardiac strain.

Conclusions:

  • Active RAAS control effectively preserves renal function in CKD patients undergoing CABG.
  • This therapeutic strategy may lead to improved early postoperative outcomes and long-term reduction in cardiovascular events.
Abstract

More Related Videos

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

4.4K
Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

842

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.8K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.7K
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
3.0K
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
36.7K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
580